STVZX
Price
$10.59
Change
-$0.07 (-0.66%)
Updated
Aug 15 closing price
Net Assets
610.59M
VIVIX
Price
$70.31
Change
-$0.09 (-0.13%)
Updated
Aug 15 closing price
Net Assets
195.81B
Interact to see
Advertisement

STVZX vs VIVIX

Header iconSTVZX vs VIVIX Comparison
Open Charts STVZX vs VIVIXBanner chart's image
Virtus Ceredex Large-Cap Value Equity R6
Price$10.59
Change-$0.07 (-0.66%)
VolumeN/A
Net Assets610.59M
Vanguard Value Index I
Price$70.31
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets195.81B
STVZX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
STVZX vs. VIVIX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STVZX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 196B vs. STVZX (611M). VIVIX pays higher dividends than STVZX: VIVIX (2.19) vs STVZX (1.45). STVZX was incepted earlier than VIVIX: STVZX (11 years) vs VIVIX (27 years). STVZX (0.88) is less costly to investors than VIVIX (0.04). STVZX is a more actively managed with annual turnover of: 112.00 vs. VIVIX (9.00). STVZX has a lower initial minimum investment than VIVIX: STVZX (2500000) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 7.91 vs. STVZX (-9.00). VIVIX return over 5 years is better than : 68.54 vs. STVZX (-6.23).
STVZXVIVIXSTVZX / VIVIX
Total Expense Ratio0.720.041,800%
Annual Report Gross Expense Ratio0.880.042,200%
Fund Existence11 years27 years-
Gain YTD4.8516.53374%
Front LoadN/AN/A-
Min. Initial Investment2500000500000050%
Min. Initial Investment IRAN/AN/A-
Net Assets611M196B0%
Annual Yield % from dividends1.452.1966%
Returns for 1 year-9.007.91-114%
Returns for 3 years-2.4625.93-10%
Returns for 5 years-6.2368.54-9%
Returns for 10 years-26.68114.61-23%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALDX5.390.09
+1.70%
Aldeyra Therapeutics
SOTK3.300.04
+1.23%
Sono-Tek Corp
CRL156.680.88
+0.56%
Charles River Laboratories International
BANFP26.00N/A
N/A
BancFirst Corp
TRS36.77-0.20
-0.54%
TriMas Corp